Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass
- 1 October 1991
- journal article
- clinical trial
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 102 (4) , 515-525
- https://doi.org/10.1016/s0022-5223(20)31421-5
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins.The Journal of Experimental Medicine, 1989
- Effect of High-Dose Glucocorticoid Therapy on Mortality in Patients with Clinical Signs of Systemic SepsisNew England Journal of Medicine, 1987
- A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 1987
- Cachectin: More Than a Tumor Necrosis FactorNew England Journal of Medicine, 1987
- Isolation and characterization of lipocortin (lipomodulin)Inflammation Research, 1986
- Enhanced fibrinolytic activity during cardiopulmonary bypass in open‐heart surgery in man is caused by extrinsic (tissue‐type) plasminogen activatorEuropean Journal of Clinical Investigation, 1984
- Proteases and oxidants in experimental pulmonary inflammatory injury.Journal of Clinical Investigation, 1984
- Effects of Dexamethason on the Early Postoperative Course after Coronary Artery Bypass SurgeryThe Thoracic and Cardiovascular Surgeon, 1982
- Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response.Proceedings of the National Academy of Sciences, 1981
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981